<SUBMISSION>
<ACCESSION-NUMBER>0000950134-03-008943
<TYPE>8-K
<PUBLIC-DOCUMENT-COUNT>3
<PERIOD>20030606
<ITEMS>9
<FILING-DATE>20030606
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>ADVANCED NEUROMODULATION SYSTEMS INC
<CIK>0000351721
<ASSIGNED-SIC>3841
<IRS-NUMBER>751646002
<STATE-OF-INCORPORATION>TX
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>8-K
<ACT>34
<FILE-NUMBER>000-10521
<FILM-NUMBER>03735218
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>6501 WINDCREST DRIVE SUITE 100
<CITY>PLANO
<STATE>TX
<ZIP>75024
<PHONE>9723098000
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>6501 WINDCREST DRIVE SUITE 100
<CITY>PLANO
<STATE>TX
<ZIP>75024
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>QUEST MEDICAL INC
<DATE-CHANGED>19920703
</FORMER-COMPANY>
</FILER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d06604e8vk.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
<TITLE>e8vk</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<P align="center"><FONT size="4"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</B></FONT>

<DIV align="center"><B><FONT size="3">Washington, DC 20549</FONT></B></DIV>

<P align="center"><FONT size="5"><B>FORM 8-K</B></FONT>

<P align="center"><FONT size="3"><B>CURRENT REPORT<BR>
PURSUANT TO SECTION 13 or 15(d) OF THE<BR>
SECURITIES EXCHANGE ACT OF 1934</B>
</FONT>

<P align="center"><FONT size="2">Date of report (Date of earliest event reported):<BR>
June&nbsp;6, 2003 (June&nbsp;6, 2003)
</FONT>
<P align="center"><FONT size="6"><U>Advanced Neuromodulation Systems, Inc.</U></FONT>

<DIV align="center"><FONT size="2"><B>(Exact name of registrant as specified in charter)</B></FONT></DIV>

<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="85%">
<TR valign="bottom">
    <TD width="31%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><FONT size="2"><u>Texas</u></FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="center" valign="top"><FONT size="2">
<u>0-10521</u>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="center" valign="top"><FONT size="2"><u>75-1646002</u></FONT></TD>
</TR>

<TR valign="bottom">
    <TD align="center" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="center" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="center" valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD align="center" valign="top"><FONT size="2"><B>(State or Other<BR>
Jurisdiction of<BR>
Incorporation)</B></FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="center" valign="top"><FONT size="2">
<B>(Commission File<BR>
Number)</B>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="center" valign="top"><FONT size="2"><B>(IRS Employer<BR>
Identification No.)</B></FONT></TD>
</TR>
</TABLE>
</CENTER>
<P align="center"><FONT size="2">6501 Windcrest Drive, Suite&nbsp;100<BR>
<u>Plano, Texas 75024</u><BR>
<B>(Address of principal executive offices) (Zip code)</B>
</FONT>
<P align="center"><FONT size="2">Registrant&#146;s telephone number, including area code:<BR>
(972)&nbsp;309-8000
</FONT>
<P align="center"><FONT size="2">&nbsp;</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<!-- TOC -->
<A name="toc"><DIV align="CENTER" style="page-break-before:always"><U><B>TABLE OF CONTENTS</B></U></DIV></A>

<P><CENTER>
<TABLE border="0" width="90%" cellpadding="0" cellspacing="0">
<TR>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="76%"></TD>
</TR>
<TR><TD></TD><TD colspan="8"><A HREF="#000">Item&nbsp;9. Regulation&nbsp;FD Disclosure.</A></TD></TR>
<TR><TD colspan="9"><A HREF="#001">SIGNATURES</A></TD></TR>
<TR><TD colspan="9"><A HREF="#002">INDEX TO EXHIBITS</A></TD></TR>
<TR><TD colspan="9"><A HREF="d06604exv99w1.htm">EX-99.1 Press Release dated June 6, 2003</A></TD></TR>
</TABLE>
</CENTER>
<!-- /TOC -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>




<!-- link2 "Item&nbsp;9. Regulation&nbsp;FD Disclosure." -->
<DIV align="left"><A NAME="000"></A></DIV>
<P align="left"><FONT size="2"><B>Item&nbsp;9. Regulation&nbsp;FD Disclosure.</B>
</FONT>

<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On June&nbsp;6, 2003, we issued a press release announcing that our Board of
Directors has declared a 3-for-2 split of our common stock, $0.05 par value per
share. The split, which will be effected in the form of a 50% stock dividend
(one share of common stock payable for every two shares held), is payable on
July&nbsp;11, 2003 to shareholders of record on June&nbsp;20, 2003. There currently are
12,818,103 ANS common shares outstanding. Accordingly, if no other shares of
common stock are issued prior to the record date, the number of shares of
common stock outstanding following the stock split will be 19,227,154.
Fractional shares will be settled by rounding up to the nearest whole share.
The Company&#146;s transfer agent is Computershare Investor Services, Inc., Chicago.
For additional information, see the press release attached hereto as Exhibit
99.1.
</FONT>
<P align="center"><FONT size="2">2</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
<!-- link1 "SIGNATURES" -->
<DIV align="left"><A NAME="001"></A></DIV>
<P align="center"><FONT size="2"><B>SIGNATURES</B>
</FONT>

<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dated: June&nbsp;6, 2003
</FONT>
<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="85%">
<TR valign="bottom">
    <TD width="32%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD colspan="5" valign="top" align="left"><FONT size="2">ADVANCED NEUROMODULATION SYSTEMS, INC.</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">By:</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD colspan="3" valign="top" align="left"><FONT size="2">/s/ F. ROBERT MERRILL III</FONT><HR size="1" noshade></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">Name:</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">F. Robert Merrill III</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">Title:</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">Executive Vice President, Finance,</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">Chief Financial Officer and Treasurer</FONT></TD>
</TR>
</TABLE>
</CENTER>
<P align="center"><FONT size="2">3</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
<!-- link1 "INDEX TO EXHIBITS" -->
<DIV align="left"><A NAME="002"></A></DIV>
<P align="center"><FONT size="2"><B>INDEX TO EXHIBITS</B>
</FONT>

<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="75%">
<TR valign="bottom">
    <TD width="13%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="82%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="center"><FONT size="1"><B>Exhibit</B></FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="center"><FONT size="1"><B>Number</B></FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD nowrap align="center"><FONT size="1"><B>Description</B></FONT></TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="center"><HR size="1" noshade></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD nowrap align="center"><HR size="1" noshade></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">99.1</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Press Release dated June&nbsp;6, 2003</FONT></TD>
</TR>
</TABLE>
</CENTER>
<P align="center"><FONT size="2">4</FONT>
</BODY>
</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>d06604exv99w1.htm
<DESCRIPTION>EX-99.1 PRESS RELEASE DATED JUNE 6, 2003
<TEXT>
<HTML>
<HEAD>
<TITLE>exv99w1</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<P align="right"><FONT size="2"><B><B>Exhibit&nbsp;99.1</B></B>
</FONT>

<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
    <TD width="45%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="13%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="32%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2"><IMG src="d06604d0660405.jpg" alt="(ANS LOGO)"></FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD colspan="3" valign="middle" align="right"><FONT size="4">FOR IMMEDIATE RELEASE</FONT></TD>
</TR>
<TR>
    <TD colspan="5" valign="top" align="left"><HR size="1" noshade></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2"><B>Agency Contact:</B></FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2"><B>Company Contact:</B></FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">Neil Berkman Associates</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">Chris Chavez, President &#038; CEO</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">(310) 277-5162</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">(972) 309-8000</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">info@BerkmanAssociates.com</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">www.ANSmedical.com</FONT></TD>
</TR>
</TABLE>
</CENTER>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>
<P align="left"><FONT size="2"><B>ADVANCED NEUROMODULATION SYSTEMS, INC.</B><BR>
6501 WINDCREST DRIVE, SUITE 100 / PLANO, TEXAS 75024 / (972)&nbsp;309-8000 / FAX: (972)&nbsp;309-8150
</FONT>

<P align="center"><FONT size="2"><B>Advanced Neuromodulation Systems Announces<BR>
Three-For-Two Stock Split</B>
</FONT>

<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;DALLAS, TEXAS, June&nbsp;6, 2003 &#151; <B>Advanced Neuromodulation Systems, Inc.
(ANS) (NASDAQ:ANSI) </B>announced today that its Board of Directors has declared a
3-for-2 split of the company&#146;s common stock.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The split, which will be effected in the form of a 50% stock dividend (one
share of common stock payable for every two shares held), is payable on July
11, 2003 to shareholders of record on June&nbsp;20, 2003. There currently are
12,818,103 ANS common shares outstanding. Accordingly, if no other shares of
common stock are issued prior to the record date, the number of shares of
common stock outstanding following the stock split will be 19,227,154.
Fractional shares will be settled by rounding up to the nearest whole share.
The Company&#146;s transfer agent is Computershare Investor Services, Inc., Chicago.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;President and Chief Executive Officer Chris Chavez said, &#147;ANS&#146; Board of
Directors and management team are dedicated to the enhancement of shareholder
value. This stock split is a tangible way for us to make the benefits of the
company&#146;s strong performance available to our shareholders. It is also a sign
of our confidence in ANS&#146; continued growth and leadership in the
neuromodulation industry.&#148;
</FONT>
<P align="left"><FONT size="2"><B>About Advanced Neuromodulation Systems</B>
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Advanced Neuromodulation Systems designs, develops, manufactures and
markets implantable systems used to manage chronic intractable pain and other
disorders of the central nervous system. Forbes magazine recently recognized
ANS as one of America&#146;s 200 Best Small Companies. Frost &#038; Sullivan, an
international strategic market research firm, also recently presented ANS with
its Product Innovation Award, recognizing ANS as the technology innovation
leader in the neurostimulation market and ANS&#146; <I>Genesis&#174; </I>Implantable Pulse
Generator system as the most advanced fully implantable spinal cord stimulator
on the market. Additional information is available at www.ans-medical.com.
</FONT>


<P align="center"><FONT size="2">&nbsp;</FONT>
</BODY>
</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>d06604d0660405.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 d06604d0660405.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````4```_^X`#D%D
M;V)E`&3``````?_;`(0``@("`@("`@("`@,"`@(#!`,"`@,$!00$!`0$!08%
M!04%!04&!@<'"`<'!@D)"@H)"0P,#`P,#`P,#`P,#`P,#`$#`P,%!`4)!@8)
M#0L)"PT/#@X.#@\/#`P,#`P/#PP,#`P,#`\,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,_\``$0@`,0",`P$1``(1`0,1`?_$`:(````'`0$!`0$`````
M``````0%`P(&`0`'"`D*"P$``@(#`0$!`0$``````````0`"`P0%!@<("0H+
M$``"`0,#`@0"!@<#!`(&`G,!`@,1!``%(1(Q05$&$V$B<8$4,I&A!Q6Q0B/!
M4M'A,Q9B\"1R@O$E0S13DJ*R8W/"-40GDZ.S-A=49'3#TN(()H,)"A@9A)1%
M1J2T5M-5*!KRX_/$U.3T976%E:6UQ=7E]69VAI:FML;6YO8W1U=G=X>7I[?'
MU^?W.$A8:'B(F*BXR-CH^"DY25EI>8F9J;G)V>GY*CI*6FIZBIJJNLK:ZOH1
M``("`0(#!04$!08$"`,#;0$``A$#!"$2,4$%41-A(@9Q@9$RH;'P%,'1X2-"
M%5)B<O$S)#1#@A:24R6B8[+"!W/2->)$@Q=4DP@)"A@9)C9%&B=D=%4W\J.S
MPR@IT^/SA)2DM,34Y/1E=865I;7%U>7U1E9F=H:6IK;&UN;V1U=G=X>7I[?'
MU^?W.$A8:'B(F*BXR-CH^#E)66EYB9FIN<G9Z?DJ.DI::GJ*FJJZRMKJ^O_:
M``P#`0`"$0,1`#\`]A?FE^;_`/SF#HW_`#G=^7_Y;^3/+6O77_.-NIS:*OF?
M7+?RJUWIT:7$;F]]361:N(N+`5_>CC[8J[\MOS@_YS!U;_G//SQ^6OFWRUKU
MM_SC5ITVL+Y=UV?RJUKISI!;*]GPUHVJB3E(2!^]/+IOBKQC\BOS_P#^?@'F
M3\O_`/G+'5/S(\F^:+'S1Y)\J_7?R2M[OR0]A+=ZGZER.%K`;&/ZZW%(_@`?
MMMOBJK:?G[_SGX__`#@]JGYB3^3O,X_YR*A_,==*L]$/DAUU`^7S;PN91H_U
M*K1^HS#UO2]N6V*J?YO?G]_SG_H?_.+7_.-'G+R+Y-\T7?YS>;IM=7\W-+MO
M)#WEY;);7+)8_6=-%DYM.48!6L:\^N^*OUY\DWFL:AY,\HW_`)ABDAU^^T6P
MN-<AEB]"1+R6WC>X5XJ+P(D)!6@ITIBK)\5?S>WG_/U+\X+?_G,*;3X?.=K-
M_P`XW1?F`-(.AC2]/JWE];@6+W*WGU<752H-R*RUK\->/PXJ_I!!!`(-0>AQ
M5XC_`,Y+^;?-/D'_`)Q[_.GSOY)NVL/-OE'R;K&L>7K]8([HP75G:231R^C,
MDD;A"M2'4BG44Q5^&?\`SAG_`,_4?S9U/\[-'\K?\Y,^=;36?R^\YQKI%EJZ
MZ9IVFKH^IRR+]6NII+.WA+0R']U)S)5.0DV"M55_1T""`0:@]#BK>*OQK_Y^
M%?\`.5?_`#D7^1W_`#D3^2_Y=_E%YM30O+?YB:3IXO+&72]-NQ+?3ZO-:2&*
MXO;:0JQC,:D%N(V-!6I5?H)_SE)_SDWY#_YQ3_*^\_,7SJ)=1NIYOT?Y2\JV
MK!;K5M2=&=($8@B-%52\LA!"*.C,51E7XA^4?S<_Y^E?\YOSZWYS_*'5Y/(?
MY=P7;65N=(GL]!TNWD1:F&"[N.5]=.`PYLK.%8_L;`*HWRQ_SEQ_S\>_YQG_
M`#I\C_D]^>>CKY\N//&K6&G:%HGF..T(U%+JX2S5M.US3%()+R+R9_5X&G.,
M$D%5_1]O3H.5.E=J_/%7Y=_FK^>?_.5^@_\`.>WY>_E1Y1T;5)_^<>]7FT1?
M,FIQ>6S=6B+=1N;SEJWU=O3H0*_O!Q]L5=^6?YY_\Y7ZW_SGWYZ_*;S3HNJ0
M_P#./&ES:RN@:I+Y;-O9LMM;*]IQU;ZNOJ5D)I^\/+IBKQ3\AO\`G)G_`)SH
M\U_EY_SEOJ_Y@^7=:MO,GY?>5/K_`.3D4_D\V+SZCZMRO&"'ZHGUP\43X*-\
MM\55[/\`YR7_`.<Y9/\`G!;5?S2F\O:T/S]@_,E=%M--/D\B[.A&VA<N-*^J
M;IS9OWOI^U=L54OSA_YR8_YSG\N_\XJ?\XQ^??)?EW6KC\W/.\VO+^:EE#Y/
M-W<0K:7+)9>M8?5&^JUC`I\"\NN^*OV&\CWVK:IY*\H:GKR-'KFHZ)I]UK,;
MQ^BRW<UM&\X:*@X$.35:"G3%7@'_`#FM^;Z_D=_SC!^;OGR*<P:PNB2Z/Y89
M)/3E&J:N18VLD9ZDPO-ZQ`WXH>G7%7\6MW8WUBUO]>M)K1KN!+JU]9&0R0RB
MJ2IR`JK#<$;'%7]HO_.$'YKS?G1_SBM^37GF^N#<ZS)H:Z/YAE=P\KW^C2/I
MMQ++W#3-;^M0]G![XJSC_G*"VGO?^<:O^<A+2UC,MS<_EMYJB@B%`6=](N@!
MO0;G%7\.^*OZ<O\`GU1_SF<WYM>3/^5!_F3KTEY^9OD2W+^4M4OI>4VLZ'$`
M!'S;XI)[+[+5JS1<6W*N<5?L5BK\#/\`GZI_ZUM_SAO_`,9[+_NO6^*O&O\`
MG]CYTN]1_/'\JO(0F#:;Y5\F-K"PJQ/&[UB_GBEY+6@/IV$5/GBK]=?^?;NK
M^6=5_P"<+OR07RQ/;20Z5IEU8:S;V]`T&IQ7UPUXDR#=7:1S(:_:#!^C`XJ^
MB?S)_)7R+^:NO_E9YF\UV<LFM?D]YFC\U>3KVW,2LMVD+Q&&4R1R$PN621E4
MJ2\<;<OAH57K6*OR\_-7\^O^<J?+_P#SGK^7OY1^4]#U"?\`YQ_UF;1%\Q:K
M'Y<:YMD6ZC<W?+51"PCH0*_&..*M?EI^?7_.5.N?\Y]>>?RA\SZ'?P_\X^:5
M-K"Z#JTGEQK>V9;:V5[7CJIA`DJY-/C^+IBKQ7\A_P#G*+_G.'S;^7O_`#EM
MK/G_`,M:K:>8_P`NO*GZ0_*"&;RB]DUQJ/JW*\8H3;K];/&-/@`;Y;XJK6?_
M`#D__P`YO2?\X+ZK^:\WEK5!^?-O^9*Z)::6?*3BX.AFVA<R#2_J]2O-F_>\
M/:NV*J?YP_\`.4/_`#G!Y;_YQ5_YQD_,#R9Y:U2X_-GSU-KR_FC81>47NIH%
MM+EH[/U+`6[&UJ@%*JO+KBK]A/(]_JNJ^2_*&J:ZC1:WJ6B:?=:S&\?HLMU-
M;1O.#%0<"')^&FW3%7XR?\_>/.VJ^>?,/_./?_.)/D^X5_,'YAZ];:QJMH=A
MSNISI6CAV%?A:66X9A_D*?#%7S1_S]R_YQVT+\I8/^<</,?D[3!:^7]/\J+^
M7MY<K6K-H$<;V#3;4,DD4LM6ZMPWZ8J]@_Y\F_G'RB_-G\A=2O!^[,/G7RG:
MMUHW"QU0`^`(M6`]V/CBK]H/S\_\D5^=7_@!^8_^Z9<8J_G-_P"<2?\`G#G3
M_P#G++_G"?\`-*/0TMK#\V_(_P"85W??E_K$H5!<UT?3S-I5Q*:4BN:#BQ-$
MD"M]GF&5?F7HFL^??R5_,:RUG3'OO)7YB_EUK'.,2QF*ZL-0LI"KQRQ..H8%
M'1A0BJD4.*O[%?\`G#S_`)RC\K_\Y6_D]H_GK2Y;:S\WZ:D6G_F1Y6B)#:;J
MJI5^",6;T)Z&2!B35?A)YHX"K\M_^?JG_K6W_.&__&>R_P"Z];XJPS_G]K^5
M^KP^=/RB_.>WM9)M!U'19?)NJ7BBL=O>6=Q/?VJ.:[&>.YF*[?[K;?%7YA?\
MXU_\Y:_G+_SBOYDDUK\M-=#:-J$BOYB\D:ESGT?40M!6:!70I(`*"6-E<#:O
M&H*K^H#_`)Q&_P"<]?R?_P"<L[1M'T5YO)WYG:=:_6-9_+S560S.B@>I<:?.
MOPW4*DT-`LB]7C4%257W'BK\TOS/_P"<D_\`G)?RQ_SG)Y"_)#ROY#CU#\C=
M>ET9-?\`-IT&_N&A6\C9KHC4HY!;IP('VE^'OBKORY_YR3_YR7\Q?\YT^=?R
M-\Q^0X['\BM%FU=-$\W#0;^!I5M+=9+8_I)Y#;OS<D;+\708J\<_(_\`YS#_
M`.<R/._D'_G*K7O/'Y81:3K_`.5GE?\`2?Y56:^5]4M!J-_ZEROI&*:5FNMH
MT^&(@[^^*JUI_P`Y@?\`.8LO_.$^I_G3+^6,2_G9;?F(OEZU\J?X8U0*VC&W
MBD-Q^CC+]8)YNP]0-Q[4Q52_-K_G,+_G,CRG_P`XP?\`.-_YF^4ORPBU+\S_
M`,QIM<3\R-`/EC5+E;%;*Y:.T(LHY1-;\T`/[PGEU&*OUH\FZIJ.K^3/*NM:
MY"+/5M3T6QO=8M^#0B*XFMTDF7@Y)0*[$4)J.^*OYDM'_P"<MOREUK_GY/YC
M_P"<D_S8U.]7\N?*-SJ-G^7S:?;O?<TL+8Z5ID@B2I"R*SW6W1SBKZ7_`.<^
M/^<YO^<0/^<EO^<>O,GY=^6/,&M:AYVL+VQUSR+=S:'<PP)?VLG"16DFX%!)
M;2S15IL6!WIBK\IO^<*_SE?\B/\`G)K\J//\UVMIH::Q'I'FUY'].+]$ZK_H
M=V\IJ!2%)?6%=N2*>V*OZ^_S[(;\B/SI*D,&\A^8R"-P0=+N,5?F#_SY-_\`
M6>_S3_\`-AR_]TG3\58?_P`_7_\`G"2Y\XV-[_SE!^6&F>MYBT"Q5?S7\OVT
M8YWNGVJT35HPH!:6VC'&8;UB56%/3;DJ_&C_`)Q+_P"<F_-O_.*WYNZ-^87E
M]Y;W0;@K8>?/*P:D6J:4[`RQT.PEC_O(7_9<;_`SJRK]./\`GX?^87E'\UO^
M<@/^<$_S#\B:Q%KGE3S5%IU]I&HQ;51]>M^22*=TDC8%'1MU8%3N,5?OA^8_
MY<>2OS;\EZ]^7WYA:!;>9/*?F2V:VU/3+E:['[,L3CXHY8VHR2(0R,`RD$8J
M_FA_YRS_`.?4_P":_P"3<VL><?R:2Z_-C\L;<-<&QA4/YBTV$"K">UC51=*G
M\\`Y4W:-:5Q5^9/D'SSYG_+#SMY7_,#R=J#Z3YI\G:E!J>C7J_L3V[A@KKT9
M'%5=3LRDJ=CBK^TC_E?^B_\`0K__`$,M]2?]#_\`*O/\=?HG?G7]'?7?JM?'
MG^[KX[],5?)?YI?\Y0?\Y%>5?^<[/R__`"&\M^4;6\_)?S#+HJ:YYC?1;R>:
M);V-VN::@DH@3B0*57;OBK7Y;?\`.4/_`#D5YE_YSR\[_D'Y@\HVMI^2NAS:
MPFC^9%T6\AFD6SMEDMR=0>4P/R<D;+OVQ5XS^1?_`#FK_P`Y;^?/R_\`^<L/
M,/G/R%8Z=KGY2^5OTK^6-M'Y=U"U6]OO4N5]-XY9F:X%(D^&,@[^^*JUI_SF
ME_SEI-_S@_JGYYR^0[%?SCM?S&7RW;>7O\.Z@(3I!MX9#-]0];UB>;L.?+C[
M8JI?F[_SFI_SEMY/_P"<6_\`G&G\U?*WD*QOOS(_,V;74_,+1W\NZA<1VBV%
MRT5J4M(YA+!R0`GFQY=L5?77_.7'Y\W'Y4_\X3^:?S&U@I9><?-_E"TT?1[-
M>5NPUOS#:+`3$AJRFW]62?B36D9%>^*OSK_Y]U_\^[?R*_-C_G'_`$O\V_SV
M\FW'F_5O.NIW\GEBR_2FI:=#;Z5:2"SC+)87%LS.\\$SU+$<"N*OO"[_`.?6
M/_.#%S!)##^3,UA(XHMU!YE\Q-(ON!-J4B?>IQ5_+?\`\Y#?E9<_DE^>'YH_
ME7<12QQ^2_,-Y9:6T]?4ET]G]6PF8FE?5M9(Y*_Y6*OZ@?('Y[?\KG_Y]L^:
M_P`SE:*?S!I_Y2^9=-\SPD$*-6T;2;FVN"RUJ!*8Q*!7[+C%7S[_`,^3?_6>
M_P`T_P#S8<O_`'2=/Q5^RTD<<T<D,T:RQ2J4EB<!E96%""#L01BK^3__`)^3
M?\X47?\`SC;^8DWY@^1M,8_DI^8E]+-I"P1GT]!U*6LDNER<118CN]L33X*Q
M[F,LRKXA_)[5=3NOS3_)?2KG4+FXTS2O.FD/I>GR2LT-N;C4K9IC"A)">H5!
M;B-R*G%7]KNM?FGY*\O?F/Y)_*G5]5^I^=/S#T_5=2\I:<Z'A=1:,(6NU63[
M/-4F#A>I56/13BKT3%7\G'_/V3\JO)GY7?\`.5<LGDK3X-(M?S"\LV7FO6])
MM46."'4KF[O+6X>.-:!?6^JB5A3=V8]\5?M'_P`JNU__`*)9?\JX_1=U_B?_
M`)4EZ_Z%^/ZS]=_1_P"D/JW#CRY^I\'"G7X<52G\T_\`G,#\[O)O_.=WY?\`
M_.-VA>4="O/RK\SS:*FK^8[C3=0EU&(:A&[3F.[CNTMUXE13E":=ZXJU^6W_
M`#F!^=_FW_G//SQ_SC5K7E'0K3\JO+LVL)I?F2#3=0CU&1;"V66#G=R7;VS<
MF-#QA%>U,5>,?D5_SG__`,Y)_F1^7_\`SECYG\T^0O+&G:O^2?E7],^0;6TT
M?58([V[]2Y3T[I)K^1IEI"NT3(=SOBJM:?\`.?G_`#DC/_S@[JG_`#D5)Y#\
MLK^9]G^8Z^5(/+PT?51IYTPVT,IF-J;_`.L&3DY'(2\?\G%5+\WO^<_O^<DO
M(O\`SBS_`,XT?G+Y>\A>6+[SU^;DVNQ^=='N='U66SM%TZY:*W^KV\5^DT7)
M15O4D>O:F*OFG_GZ7^8WYH?G7<?DM^5_EGR1K>K:;H.@:;YK\[W.EZ5>260\
MP:Y:(8K<2A9`HMX')`+;>J022N*OWI_)7\OHORH_*'\LORUB,;'R-Y9TO1;B
M:(426>TMHXYY14`_O)`S[COBKT[%7\SO_/WK\A?-2_\`.26A_F+Y/\GZOKMC
M^9/E>VDU>ZTVSFO!^D]';ZC*&$*N5I:_5>H%>U=Z*I+_`,X5^<OS'\C?\X[_
M`/.9OY!^9/(_F/29/-_Y>Z]KWD.&_P!)O8A+J2Z9)9:A:1AXQREF@:)T4;_N
MFZXJ^Y?^?,GE_P`V>5_RF_.+2/-.@ZKY==O-MI>66GZK:36;L)M/16E1)T1B
M&$:BHVVQ5^R^*O-_S>_*ORE^=OY;>;_RN\\60O?+GG#3Y+*Z("F6WD/Q074!
M8$++!*%DC--F48J_D=O/^<8_S:_(?_G*/0?)/F'RCK&IV7DGSOHTK>;+'3KF
M73[K31?PRP7Z2QHZJDD5&(+50U1OB4XJ_3+_`)^LQ?\`.1_EO_G(#\G?SI_+
MCRCY@3R?^4NB17.@^?-*MVOK2UU<WLDUY]<%OS,$;Q^A&1.%25>2CD.0"J&T
M3_G^%+#Y:M(O,7_./@O_`#A%;<;ZZT_7_JNG37(!`>.*6RN)8D8T/$NY'3D>
MN*L"_('_`)Q3_/\`_P"<Z?\`G(&+_G)[_G)[0)?*OY;B^L]031M2M);8:Q:V
M?%[32M-L;@^HMCQ`YS/\+J6X&1V=E5?T=>E%Z7H>FOH\>'HT''C2G'CTI3:F
M*JF*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*OERS_`/)_W_\`QE;_`*AD
)Q2^H\4.Q5__9
`
end

</TEXT>
</DOCUMENT>
</SUBMISSION>
